Hints and tips:
Related Special Reports
The FT’s fourth annual ranking of the region’s businesses by revenue growth. Plus: companies with the ‘last-mover advantage’; cannabis corporations on the rise; is Moderna a one trick pony?
...“Winner” indicates that the organisation won an FT Innovative Lawyers North America award for 2023. The full list of award winners is available here....
...Can we recreate the social and cultural cohesion of an isolated island in politically, racially and culturally divided America?...
...Past liability management scenarios presented at JPMorgan’s high-yield and leveraged finance event this week included those of Bausch Health and Dish/EchoStar....
With real meat facing real problems, investors should cut back their exposure
...“All New Yorkers have a basic right to clean water, yet PepsiCo’s irresponsible packaging and marketing endanger Buffalo’s water supply, environment and public health,” James said on Wednesday....
...Citi, JPMorgan and Bank of America have all gotten in....
...For many farmers, regenerative agriculture is more to do with the health of their land than of their bank balances....
...Companies embracing AI stress that security and privacy are their top priority, as these devices run the gamut from cameras that scan your home to sensors that detect the most personal of health indicators...
...Some pharma companies disputed the annual cost figures published by the health department....
...On January 10 2000, Levin and America Online chair Steve Case agreed a $165bn merger....
...Letter in response to this article: America’s betting laws have had ‘intended effect’ / From Bill Miller, President & Chief Executive, American Gaming Association, Washington, DC, US...
...“The financial health of our consumers remains strong,” Wells chief executive Charlie Scharf told analysts....
...Investors clamoured for junk bonds and loans backing private equity groups’ acquisitions of financial technology company Worldpay and healthcare company Syneos Health....
...The drug will have a US list price of $26,500 a year, although health insurers will negotiate that down....
Massachusetts police chief and former pharmaceutical executive also among those indicted by federal prosecutors
...vaccines, every device that’s implanted in the body, including pacemakers, all of them depend on endotoxin testing, all of them depend on this one animal which is declining,” said Adam Kanzer, head of Americas...
...Meanwhile, investors looking for short opportunities could consult Bank of America’s “AI Risk Index”, which features . . . Adobe, the design software company....
...He was holding court on the Fox studio lot in Los Angeles this week, one of these people said, and told staff on Thursday that he was in “robust health”....
...Dan Mead, head of the investment-grade syndicate at Bank of America — a lead bookrunner on the Pfizer bond sale — said it was “not uncommon to see that for financings”....
...With a recent cancer diagnosis, Dixon feared that she would lose her health insurance if she lost her job....
...The sharp escalation in total borrowings stemmed from two recent additions — Bausch Health Companies and hospital staffing group Envision Healthcare, owned by buyout firm KKR....
...The FT’s US pharmaceutical correspondent Jamie Smyth helps us explore whether J&J’s use of this manoeuvre is setting a precedent for corporations to evade accountability in America....
...Bausch Health will remain a majority shareholder in Bausch & Lomb after the deal....
...Amgen said it would offer its biologic treatment, named Amjevita, to US health insurers and middlemen known as pharmacy benefit managers through two pricing plans....
International Edition